Endeavor Bancorp Declares 2% Stock Dividend
May 03, 2024 09:00 ET
|
Endeavor Bank
SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- Endeavor Bancorp (OTCQX: EDVR) (the “Company,” or “Bancorp”), the holding company for Endeavor Bank (the “Bank”), today announced its Board of Directors...
Celebrate National Honor Our LGBT Elders Day on May 16
May 02, 2024 14:15 ET
|
Chase Brexton Health Care
Baltimore, May 02, 2024 (GLOBE NEWSWIRE) -- Celebrate an LGBT elder who made a difference in your life, and spread the word about the importance of LGBT older adults in your community on Thursday,...
Network for Teaching Entrepreneurship and G-Unity Foundation Announce Collaboration
May 02, 2024 13:40 ET
|
Network for Teaching Entrepreneurship (NFTE)
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- The Network for Teaching Entrepreneurship (NFTE) and Curtis “50 Cent” Jackson’s G-Unity Foundation announced their collaboration to support aspiring...
Appian Announces First Quarter 2024 Financial Results
May 02, 2024 07:05 ET
|
Appian Corporation
MCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the first quarter ended March 31, 2024. “Appian continues to push technological boundaries...
Black Rock Coffee Bar Launches Summer Daze Campaign with its Summer Drink Collection
May 01, 2024 14:36 ET
|
Black Rock Coffee Bar
Scottsdale, AZ, May 01, 2024 (GLOBE NEWSWIRE) -- Black Rock Coffee Bar, a national boutique coffee chain, has announced the launch of its Summer Daze Campaign, igniting the tastes of its delicious...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
April 30, 2024 04:00 ET
|
Alvotech
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....
Alvotech semur við Quallent Pharmaceuticals um markaðssetningu á hliðstæðu við Humira í Bandaríkjunum
April 30, 2024 04:00 ET
|
Alvotech
Alvotech mun framleiða líftæknilyfjahliðstæðu sína í háum styrk með útskiptileika við Humira (adalimumab) fyrir Quallent Pharmaceuticals, dótturfélag Cigna Alvotech (NASDAQ: ALVO) tilkynnti í dag...
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
April 30, 2024 04:00 ET
|
Alvotech
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S....
Buildings across the nation to light up green for Mental Health Month in May
April 29, 2024 06:00 ET
|
Mental Health America
ALEXANDRIA, Va., April 29, 2024 (GLOBE NEWSWIRE) -- More than 200 iconic landmarks across the country will be lit in green, the color of mental health awareness, to mark the beginning of Mental...
Ibogaine Treatment for Borderline Personality Disorder Launched by Ibogaine By David Dardashti
April 25, 2024 10:54 ET
|
Ibogaine By David Dardashti
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti is proud to announce the launch of a unique therapy protocol designed to provide compassionate and holistic care for patients...